AI and Health: Discussing the New Paradigm in Evidence Generation in Milan

On January 16, 2026, Aindo hosted the event “AI & Health: The New Paradigm in Evidence Generation” in Milan. The meeting served as a forum for deep discussion on how Artificial Intelligence and synthetic data are fundamentally reshaping the way scientific evidence is generated, validated, and reused in the healthcare sector.

The day featured a highly qualified panel, including Scientific Directors of IRCCS, Medical Directors from leading pharmaceutical companies, and representatives from key research organizations. Together, we explored several pillars of the digital health revolution:

• Data governance and regulation: Navigating the importance of building a robust, collaborative framework across the entire ecosystem.
• New models for evidence generation: Shifting from traditional methods to AI-driven approaches.
• Strategic role of synthetic data: How synthetic data bridges the gap between raw information and actionable insights.
• Concrete use cases: Analyzing how AI is being applied today to improve healthcare research and decision-making processes.

This event was more than a conference; it was a collaborative effort to bridge the dialogue between institutions, research, and industry. The conversation on the future of evidence generation in healthcare is just getting started, and Aindo remains at the forefront of this transformation.